IL19 and psoriasis: We also demonstrate that our IL-19 assay has similar applicability for psoriasis patients treated with tumor necrosis factor (TNF)α inhibitors such as etanercept, or Janus associated kinase (JAK) 1/2 inhibitors such as baricitinib.